Myofunctional Therapy App for Severe Apnea-Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial

Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. We cond...

Full description

Saved in:
Bibliographic Details
Published in:JMIR mHealth and uHealth 2020-11, Vol.8 (11), p.e23123-e23123
Main Authors: O'Connor-Reina, Carlos, Ignacio Garcia, Jose Maria, Rodriguez Ruiz, Elisa, Morillo Dominguez, Maria Del Carmen, Ignacio Barrios, Victoria, Baptista Jardin, Peter, Casado Morente, Juan Carlos, Garcia Iriarte, Maria Teresa, Plaza, Guillermo
Format: Article
Language:English
Subjects:
Acoustics
Aged
Disease
Female
Hospitals
Humans
Laboratories
Male
Middle Aged
Mobile Applications
Multimedia
Myofunctional Therapy
Objectives
Original Paper
Patients
Pilot Projects
Questionnaires
Sleep
Sleep apnea
Sleep Apnea, Obstructive - therapy
Smartphones
Success
Therapists
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS. Forty patients with severe OSAHS (apnea-hypoxia index [AHI]>30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were measured before and after the intervention. After the intervention, 28 patients remained. No significant changes were observed in the control group; however, the intervention group showed significant improvements in most metrics. AHI decreased by 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/hour (P
ISSN:2291-5222
2291-5222
DOI:10.2196/23123